Previous Close | 0.9424 |
Open | 0.9400 |
Bid | 0.9549 x 800 |
Ask | 0.9552 x 800 |
Day's Range | 0.9300 - 0.9651 |
52 Week Range | 0.7080 - 1.6300 |
Volume | |
Avg. Volume | 4,760,492 |
Market Cap | 463.359M |
Beta (5Y Monthly) | 1.91 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.4700 |
Earnings Date | Feb 26, 2024 - Mar 01, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.33 |
Subscribe to Yahoo Finance Plus to view Fair Value for CLOV
Key Insights Clover Health Investments' significant individual investors ownership suggests that the key decisions are...
FRANKLIN, Tenn., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it has delivered notice to the Centers for Medicare and Medicaid Services (“CMS”) that it will exit the CMS ACO REACH Program at the end of the 2023 performance year. Written notification will also be sent to all participating ph
Clover Health and WellBe Senior Medical have teamed up to deliver home-based medical care to residents of Georgia living with multiple complex health conditions. By providing a new option for home-based medical care, Clover is helping its members achieve their health goals with access to quality care through WellBe's in-home visits. WellBe Senior Medical puts patients first by delivering medical visits to members at their home. With just one phone call, Clover members meeting clinical eligibilit